Isthmin-1 and spexin as promising novel biomarker candidates for invasive ductal breast carcinoma
- Ahmet Turk 1, Tuba Ozcan Metin 2, Tuncay Kuloglu 3, Mustafa Yilmaz 4, Gokhan Artas 5, I Hanifi Ozercan 5, Serhat Hancer 3
- Ahmet Turk 1, Tuba Ozcan Metin 2, Tuncay Kuloglu 3
- 1Department of Histology and Embryology, Faculty of Medicine, Adiyaman University, Adiyaman, Turkey.
- 2Department of Histology and Embryology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
- 3Department of Histology and Embryology, Faculty of Medicine, Firat University, Elazıg, Turkey.
- 4Department of Emergency Medicine, Firat University School of Medicine, Elazig, Turkey.
- 5Department of Pathology, Firat University, School of Medicine, Elazig, Turkey.
- 0Department of Histology and Embryology, Faculty of Medicine, Adiyaman University, Adiyaman, Turkey.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study found that isthmin-1 (ISM-1) protein levels decrease while spexin (SPX) protein levels increase in invasive ductal breast carcinoma. These changes in breast cancer biomarkers warrant further investigation into their role in tumor development.
Area Of Science
- Oncology
- Biochemistry
- Molecular Biology
Background
- Breast cancer is a leading cause of cancer-related death in women.
- Identifying novel biomarkers is crucial for understanding breast cancer progression.
- Isthmrin-1 (ISM-1) and spexin (SPX) are novel proteins requiring further investigation in breast cancer.
Purpose Of The Study
- To investigate the expression patterns of ISM-1 and SPX in invasive ductal breast carcinoma.
- To analyze the correlation between ISM-1 and SPX expression and breast cancer clinicopathologic features.
Main Methods
- The study included 60 invasive ductal carcinoma patients (Grades I-III) and 20 healthy controls.
- Immunohistochemistry was used to analyze ISM-1 and SPX levels in tissue samples.
- Clinicopathologic data, including tumor diameter, were collected and analyzed.
Main Results
- Tumor diameter significantly increased from Grade I to Grade II and Grade III.
- Isthmrin-1 (ISM-1) immunoreactivity significantly decreased in tumors compared to normal tissue.
- Spexin (SPX) immunoreactivity significantly increased in tumors compared to normal tissue.
- No significant differences in ISM-1 or SPX expression were observed between different tumor grades.
Conclusions
- The study identified distinct expression patterns for ISM-1 and SPX in invasive ductal breast carcinoma.
- Decreased ISM-1 and increased SPX suggest a potential role in breast cancer development.
- Further research is needed to explore the relationship between these adipokines and breast cancer progression.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

